XML 10 R3.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated condensed statements of profit or loss - USD ($)
shares in Thousands, $ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Consolidated condensed statements of profit or loss [Abstract]    
Revenue $ 918,744 $ 858,583
Other operating income 91,616 57,402
Employee benefit expenses (85,174) (76,051)
Depreciation, amortization, and impairment charges (325,578) (310,502)
Other operating expenses (291,943) (237,930)
Operating profit 307,665 291,502
Financial income 16,320 17,414
Financial expenses (245,011) (243,083)
Net exchange differences (5,700) (244)
Other financial expense, net (20,319) (12,011)
Financial expense, net (254,710) (237,924)
Share of profit of entities carried under the equity method 15,122 6,905
Profit before income tax 68,077 60,483
Income tax (28,919) (11,587)
Profit for the period 39,158 48,896
Profit attributable to non-controlling interest (6,482) (2,846)
Profit for the period attributable to the Company $ 32,676 $ 46,050
Weighted average number of ordinary shares outstanding - basic (in shares) 116,161 116,149
Weighted average number of ordinary shares outstanding - diluted (in shares) 119,971 119,717
Basic earnings per share (in dollars per share) $ 0.28 $ 0.4
Diluted earnings per share (in dollars per share) [1],[2] $ 0.28 $ 0.4
[1] The potential ordinary shares related to the Green Exchangeable Notes and the long-term incentive plans granted to employees have not been considered in the calculation of diluted earnings per share for the nine-month periods ended September 30, 2024, and 2023, as they have an antidilutive effect.
[2] Antidilutive effect applied, where applicable (see Note 22)